Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
Eledon Pharmaceuticals, Inc. See All Filings	D	2024-05-22 19:36:20 UTC
Amount To Be Raised Indefinite Associated Brokers / Dealers Leerink Partners LLC and Noble Capital Markets, Inc. CIK Number 0001404281 Filed Document 0001404281-24-000002 Exclusions or Exemptions 506b Accepted Date 2024-05-22 19:36:20 UTC Type of Offering D Industry Biotechnology Principal Place of Business CALIFORNIA Revenue or Assets $No Revenues Type of Security Equity
Eledon Pharmaceuticals, Inc. See All Filings	D	2023-05-22 13:26:37 UTC
Amount To Be Raised Indefinite Associated Brokers / Dealers SVB Securities LLC and Noble Capital Markets, Inc. CIK Number 0001404281 Filed Document 0001404281-23-000002 Exclusions or Exemptions 506b Accepted Date 2023-05-22 13:26:37 UTC Type of Offering D Industry Biotechnology Principal Place of Business CALIFORNIA Revenue or Assets $No Revenues Type of Security Equity
Novus Therapeutics, Inc. See All Filings	D	2020-09-25 15:31:48 UTC
Amount To Be Raised $108,144,151 Associated Brokers / Dealers SVB Leerink LLC and Noble Capital Markets, Inc. CIK Number 0001404281 Filed Document 0001209191-20-052086 Exclusions or Exemptions 506b Accepted Date 2020-09-25 15:31:48 UTC Type of Offering D Industry Biotechnology Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity
Novus Therapeutics, Inc. See All Filings	D	2020-01-27 16:30:54 UTC
Amount To Be Raised $5,828,999 Associated Brokers / Dealers H.C. Wainwright & Co., LLC CIK Number 0001404281 Filed Document 0001209191-20-004993 Exclusions or Exemptions 506b Accepted Date 2020-01-27 16:30:54 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Option To Acquire
Novus Therapeutics, Inc. See All Filings	D	2019-05-10 16:01:50 UTC
Amount To Be Raised $28,455,174 Associated Brokers / Dealers H.C. Wainwright and Co., LLC CIK Number 0001404281 Filed Document 0001209191-19-028847 Exclusions or Exemptions 506b Accepted Date 2019-05-10 16:01:50 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Option To Acquire